C. Gobbi

Discipline

Psychologie (3) Histoire, Philosophie et Sociologie des sciences (1)

Type de document

Articles (11) Recensions (1)

Co-auteur

Date

Source

Mot-clé

Multiple sclerosis (9) maladie (8) maladie (8) Treatment (6) Patients (6) Patients (6) Swiss (5) temps (durée) (4) analyse (4) âge (4) Time (4) Symptoms (4) Persons (4) Months (4) Age (4) Age (4) Analysis (4) thérapie (3) adulte (3) Value (3) Therapeutics (3) Serum (3) Prognosis (3) Manufacturers' agents (3) Human beings (3) Commission merchants (3) Disabilities (3) Influence (3) Relapse (3) Prognosis (3)

Documents écrit par C. Gobbi (11) | parle de C. Gobbi (0)

Association of Spinal Cord Atrophy and Brain Paramagnetic Rim Lesions With Progression Independent of Relapse Activity in People With MS.
A. Cagol et al. (9 janv. 2024)
The Real-World Experiences of Persons With Multiple Sclerosis During the First COVID-19 Lockdown: Application of Natural Language Processing.
D. Chiavi et al. (10 nov. 2022)
Sleep-Related Breathing Disorders in Multiple Sclerosis: Prevalence, Features and Associated Factors.
D. Sparasci et al. (2022)
Intrathecal Immunoglobulin M Synthesis is an Independent Biomarker for Higher Disease Activity and Severity in Multiple Sclerosis.
J. Oechtering et al.
Congenital heart disease in the ESC EORP Registry of Pregnancy and Cardiac disease (ROPAC)
Karishma P. Ramlakhan et al.
Multiple Sclerosis Therapy Consensus Group (MSTCG): position statement on disease-modifying therapies for multiple sclerosis (white paper).
H. Wiendl et al. (2021)
How do patients enter the healthcare system after the first onset of multiple sclerosis symptoms? The influence of setting and physician specialty on speed of diagnosis.
L. Barin et al.
60/30: 60% of the Morbidity-Associated Multiple Sclerosis Disease Burden Comes From the 30% of Persons With Higher Impairments.
M. Kaufmann et al. (2020)
Neurologic complications of acute hepatitis E virus infection.
P. Ripellino et al.
Factors associated with time from first-symptoms to diagnosis and treatment initiation of Multiple Sclerosis in Switzerland.
M. Kaufmann et al. (2018)
The Swiss Multiple Sclerosis Cohort-Study (SMSC): A Prospective Swiss Wide Investigation of Key Phases in Disease Evolution and New Treatment Options.
G. Disanto et al. (2016)